Recently, the Brazilian National Health Supervision Agency (ANVISA) appointed a team of experts and teachers to audit the certification of Longterm Medical Factory. After a rigorous audit that lasted four days, the longterm factory met 100% of all standards and completed the ANVISA certification audit, successfully passing with "zero defects."

ANVISA certification of medical devices is a key step in the international recognition of manufacturing companies and products. It aims to ensure that the research and development process of medical devices complies with the regulations and standards of the Brazilian National Health Supervision Agency (ANVISA). The review covers everything from product design to performance testing.

In this audit, from checking records, and on-site inspections to interview questions, the expert group strictly reviewed design and development, process verification, document control, and after-sales service in terms of research and development, procurement, production, and sales. In the end, the Brazilian ANVISA expert group unanimously believed that Longterm's medical production system, quality system, management system, etc. are all safe and effective and have international leading standards. 100% meets the certification requirements, and there is no non-compliance item, passing the audit in one go.

At present, Longterm Medical Division includes but is not limited to international certifications such as CE (European Union), FDA (United States), ANVISA (Brazil), CECMED (Cuba), KGMP (South Korea), etc. The company will take this audit as an opportunity to continue to improve quality management levels and enhance product excellence, providing a strong guarantee for expanding the Brazilian and global markets.